PRINTABLE FRAUD FINDINGS for Each Vaccine ManufacturerUS Vaccine Manufacturers as listed by the CDC
- MERCK:
"Merck has been involved in a long federal lawsuit with allegations of fraud over the mumps portion of the MMR vaccine, in a case filed back in 2010 by two whistleblowers, virologists who worked for Merck. Merck has apparently tried hard to get this case thrown out of court, and keep this news out of the media, but late in 2014 a federal judge finally ruled that the case is to move forward." more - United States of America vs. Merck (2:10-CV-04374-CDJ) is a current case in which former virologists, now whistleblowers, allege Merck falsified data with regards to the efficacy of the MMRII vaccine.
- GlaxoSmithKline
Dept of Justice Press Release: GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data : Largest Health Care Fraud Settlement in U.S. History <source document>
- Sanofi
FBI Reports: Sanofi U.S. Agrees to Pay $109 Million to Resolve False Claims Act Allegations of Free Product Kickbacks to Physicians
US Senate Committee on Finance Reports:
*Fraud in Clinical Trial of drug
* Sanofi Accused Of Fraud In Clinical Trial Of Drug
*FBI reports: Two Former Pharmaceutical/Medical Technology Executives Sentenced for Their Roles in Insider Trading Scheme
Wall Street Journal: Did Merck Unfairly Monopolize the Market for a Mumps Vaccine?
“The ultimate victims here are the millions of children who, every year, are being injected with a mumps vaccine that is not providing them with an adequate level of protection,” the lawsuit filed by the virologists states. And while federal health officials have said the disease was supposed to have been eradicated by now, “the failure of Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur.” Meanwhile, the mumps vaccine was ringing the register at Merck, which reported that sales reached $621 million last year, when including both the MMR II vaccine – which is mumps, measles and rubella – and the ProQuad vaccine, a combination product that is also used to thwart chickenpox, according to a filing with the U.S. Securities and Exchange Commission.
UNITED STATES OF AMERICA et al. v. MERCK & CO.“The ultimate victims here are the millions of children who, every year, are being injected with a mumps vaccine that is not providing them with an adequate level of protection,” the lawsuit filed by the virologists states. And while federal health officials have said the disease was supposed to have been eradicated by now, “the failure of Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur.” Meanwhile, the mumps vaccine was ringing the register at Merck, which reported that sales reached $621 million last year, when including both the MMR II vaccine – which is mumps, measles and rubella – and the ProQuad vaccine, a combination product that is also used to thwart chickenpox, according to a filing with the U.S. Securities and Exchange Commission.
Pennsylvania Eastern District Court, Case No. 2:10-cv-04374-CDJ
District Judge C. DARNELL JONES, II, presiding
Concerned Citizens of California OPPOSE SB277, which mandates a rigid vaccine schedule for ALL children who do not possess a medical exemption.
United States of America vs. Merck (2:10-CV-04374-CDJ) is a current case in which former virologists, now whistleblowers, allege Merck falsified data with regards to the efficacy of the MMRII vaccine.
No comments:
Post a Comment